Pharmacoeconomics: NICE's approach to decision-making
Br J Clin Pharmacol
.
2010 Sep;70(3):346-9.
doi: 10.1111/j.1365-2125.2009.03589.x.
Authors
Michael Rawlins
1
,
David Barnett
,
Andrew Stevens
Affiliation
1
National Institute for Health and Clinical Excellence, London, UK. michael.rawlins@nice.org.uk
PMID:
20716233
PMCID:
PMC2949905
DOI:
10.1111/j.1365-2125.2009.03589.x
No abstract available
MeSH terms
Decision Making
Drug Costs*
Economics, Pharmaceutical*
Government Agencies / economics*
Humans
National Health Programs / economics*
Practice Guidelines as Topic
State Medicine / economics*
United Kingdom